Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Role of ADAR1 and dsRNA in age-related neuroinflammation and Alzheimers disease

Award Number: F31AG084330
ORGANIZATION: NATIONAL INSTITUTE ON AGING
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: FELLOWSHIP/SCHOLARSHIP/STUDENT LOANS
PERIOD OF PERFORMANCE START DATE: 08/17/2023
PERIOD OF PERFORMANCE END DATE: 07/31/2025

Group Awards By:

View Award Description

Role of ADAR1 and dsRNA in age-related neuroinflammation and Alzheimers disease - PROJECT SUMMARY The purpose of this F31 proposal is to provide support for Cali McEntee, a doctoral student at Colorado State University (CSU), while she trains to become an independent scientist conducting research on age-related neurodegeneration. With support from this award, Ms. McEntee will determine if reductions in adenosine deaminase acting on RNA 1 (ADAR1) lead to the accumulation of double-stranded RNA (dsRNA), a pathogen-associated molecular pattern that causes innate immune/inflammatory signaling, in the context of brain aging and Alzheimer’s disease (AD). Numerous reports show that ADAR1 suppresses dsRNA-related inflammation and may modulate lifespan, and that innate immune activation/neuroinflammation driven by glial cells, like astrocytes, is a central mechanism of brain aging/AD. The applicant’s preliminary data show that brain aging/AD are associated with reductions in ADAR1 levels, and that reducing ADAR1 expression in astrocytes leads to an increase in transcripts from genomic repetitive elements (RE), which are increasingly implicated in aging and neurodegeneration and predisposed to form dsRNA. As such, ADAR1 may be an important regulator of neuroinflammation with brain aging and/or AD, perhaps by reducing RE-associated dsRNA accumulation. However, this idea has not been investigated. In this project, Ms. McEntee proposes to gain valuable translational research training by using multiple models to test the hypothesis that ADAR1 reduces the deleterious effects of RE-derived dsRNA and thereby protects against age/AD-related neuroinflammation by: Aim 1) using directly reprogramed human astrocytes from healthy young/older adults and AD patients to determine if ADAR1 and dsRNA levels are related to neuroinflammation, performing total RNA-seq and RNA immunoprecipitation sequencing (RIP-seq) to identify RE-derived dsRNAs involved in neuroinflammation, and intersecting her findings with existing clinical datasets; and Aim 2) increasing expression of ADAR1 in reprogrammed human astrocytes and a pre-clinical mouse model of aging to determine if ADAR1 protects against age/AD-related neuroinflammation and cognitive dysfunction. Ms. McEntee’s immediate goal is to gain the fundamental experience and professional skills necessary to perform independent research in the field of age-related neurodegenerative diseases. Her long-term goal is to become an academic, translational researcher investigating mechanisms of aging that contribute to neurodegenerative disease. Ms. McEntee will train in a state-of-the-art environment with an exceptional mentoring team at CSU. The sponsor, Dr. LaRocca, has an extensive background studying aging and neurodegenerative diseases and directs the NIH-funded Healthspan Biology Laboratory at CSU. Under the guidance of Dr. LaRocca and consulting mentors Drs. Chris Link, Ron Tjalkens, Julie Moreno, and Dan Lark, Ms. McEntee will be able to successfully complete the training plan, supporting her development into an independent scientist.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = -$4,062 )
2026	2024	COLORADO STATE UNIVERSITY	601 S HOWES ST	FORT COLLINS	CO	80521	LARIMER	USA	Aging Research	000	2	5/28/2026	NON-COMPETING CONTINUATION	-$4,062
														Subtotal = -$4,062

Issue Date FY: 2025 ( Subtotal = -$1,176 )
2025	2025	COLORADO STATE UNIVERSITY	601 S HOWES ST	FORT COLLINS	CO	80521	LARIMER	USA	Aging Research	001	3	8/19/2025	NON-COMPETING CONTINUATION	-$40,485
2025	2025	COLORADO STATE UNIVERSITY	601 S HOWES ST	FORT COLLINS	CO	80521	LARIMER	USA	Aging Research	000	3	8/1/2025	NON-COMPETING CONTINUATION	$40,485
2025	2024	COLORADO STATE UNIVERSITY	601 S HOWES ST	FORT COLLINS	CO	80521	LARIMER	USA	Aging Research	003	2	9/12/2025	NON-COMPETING CONTINUATION	$21
2025	2024	COLORADO STATE UNIVERSITY	601 S HOWES ST	FORT COLLINS	CO	80521	LARIMER	USA	Aging Research	002	2	9/9/2025	NON-COMPETING CONTINUATION	-$1,197
														Subtotal = -$1,176

Issue Date FY: 2024 ( Subtotal = $41,627 )
2024	2024	COLORADO STATE UNIVERSITY	601 S HOWES ST	FORT COLLINS	CO	80521	LARIMER	USA	Aging Research	000	2	7/22/2024	NON-COMPETING CONTINUATION	$41,627
														Subtotal = $41,627

Issue Date FY: 2023 ( Subtotal = $39,706 )
2023	2023	COLORADO STATE UNIVERSITY	601 S HOWES ST	FORT COLLINS	CO	80521	LARIMER	USA	Aging Research	000	1	8/17/2023	NEW	$39,706
2023	2023	COLORADO STATE UNIVERSITY	601 S HOWES ST	FORT COLLINS	CO	80521	LARIMER	USA	Aging Research	001	1	8/17/2023	NEW	$0
														Subtotal = $39,706

Grand Total All Awards = $76,095

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Role of ADAR1 and dsRNA in age-related neuroinflammation and Alzheimers disease

Award Number: F31AG084330

ORGANIZATION: NATIONAL INSTITUTE ON AGING

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: FELLOWSHIP/SCHOLARSHIP/STUDENT LOANS

PERIOD OF PERFORMANCE START DATE: 08/17/2023

PERIOD OF PERFORMANCE END DATE: 07/31/2025

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer